| CTRI Number |
CTRI/2023/05/052460 [Registered on: 10/05/2023] Trial Registered Prospectively |
| Last Modified On: |
05/07/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Ayurveda |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Clinical Study to Evaluate the Efficacy of Guduchyadi yoga in Medoroga With Special Reference to Dyslipidemia |
|
Scientific Title of Study
|
A Randomized Open-Labelled Controlled Clinical Study to Evaluate The Efficacy of Guduchyadi yoga In The Management Of Medoroga With Special Reference to Dyslipidemia |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Amrutha Y |
| Designation |
PG Scholar |
| Affiliation |
Sri Sri College of Ayurvedic Science and Research |
| Address |
Room Number 304, Department of PG Studies in Kayachikitsa, Sri Sri College of Ayuervedic Science and Research, 21st KM Kanakapura Road, Udayapura Post Bengaluru, Bengaluru Rural-560082, Karnataka
Bangalore KARNATAKA 560082 India |
| Phone |
8197391854 |
| Fax |
|
| Email |
amrutha.y156@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Neelakanta J Sajjanar |
| Designation |
Professor |
| Affiliation |
Sri Sri College of Ayurvedic Science and Research |
| Address |
Room Number 304, Department of PG Studies in Kayachikitsa, Sri Sri College of Ayuervedic Science and Research, 21st KM Kanakapura Road, Udayapura Post Bengaluru, Bengaluru Rural-560082, Karnataka
Bangalore Rural KARNATAKA 560082 India |
| Phone |
8147891325 |
| Fax |
|
| Email |
neelkant.ayu@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Amrutha Y |
| Designation |
PG Scholar |
| Affiliation |
Sri Sri College of Ayurvedic Science and Research |
| Address |
Room Number 304, Department of PG Studies in Kayachikitsa, Sri Sri College of Ayuervedic Science and Research, 21st KM Kanakapura Road, Udayapura Post Bengaluru, Bengaluru Rural-560082, Karnataka
Bangalore KARNATAKA 560082 India |
| Phone |
8197391854 |
| Fax |
|
| Email |
amrutha.y156@gmail.com |
|
|
Source of Monetary or Material Support
|
| Sri Sri College of Ayurvedic Science and Research |
|
|
Primary Sponsor
|
| Name |
Dr Amrutha Y |
| Address |
Room Number 304, Department of PG Studies in Kayachikitsa, Sri Sri College of Ayuervedic Science and Research, 21st KM Kanakapura Road, Udayapura Post Bengaluru, Bengaluru Rural-560082, Karnataka |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Amrutha Y |
Sri Sri College of Ayurvedic Science and Research |
Room Number 304, Department of PG Studies in Kayachikitsa, Sri Sri College of Ayuervedic Science and Research, 21st KM Kanakapura Road, Udayapura Post Bengaluru, Bengaluru Rural-560082, Karnataka Bangalore Rural KARNATAKA |
8197391854
amrutha.y156@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Sri sri institutional ethics committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:E789||Disorder of lipoprotein metabolism, unspecified. Ayurveda Condition: MEDOROGAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Navaka guggulu, Reference: Bhaishajya Ratnavali, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -luke warm water), Additional Information: - | | 2 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Guduchyadi Yoga, Reference: Vangasena Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -1.5g Guggulu), Additional Information: -Ingridents-
1. Guduchi
2. Triphala
3. Guggulu |
|
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1. Subjects who fulfill the diagnostic criteria-
subjects will be diagnosed based on serum lipid profile- with increased levels of any of the serum lipids-
Total cholesterol >200mg/dL
LDL >129mg/dL
Triglycerides ≥150mg/dL
HDL ≤40mg/dL
VLDL ≥30mg/dL
2. Both Obese and non-obese subjects will be included. |
|
| ExclusionCriteria |
| Details |
1. Pregnant and lactating women.
2. Subjects with any uncontrolled systemic illness including Diabetes Mellitus and Hypertension.
3. Subjects who are on any medication for Dyslipidemia.
4. Subjects with any other condition interfering with the course of disease and treatment.
5. Subjects with any of the following Serum Lipid Levels-
Total cholesterol >400mg/dL
LDL >189mg/dL
Triglycerides >400mg/dL
HDL >40mg/dL
VLDL >100mg/dL
|
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Reduction in Serum Lipid Levels |
0th day
30th day
45th day |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="30" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/06/2023 |
| Date of Study Completion (India) |
10/02/2024 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
Amrutha Y, Sajjanar J Neelkant, Krishna Gopala. Efficacy of Guduchyadi Yoga in the Management of Medoroga with special reference to Dyslipidemia- A Rondomized Clinical Trial. International Journal of Ayurveda and Pharma Research. 2025;13(2):1-7. https://doi.org/10.47070/ijapr.v13i1.3549 |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
The study, “A randomized controlled parallel group
clinical study to evaluate the efficacy of
Guduchyadi yoga in the management of Medoroga w.s.r to Dyslipidemia” was undertaken to manage Dyslipidemia through Ayurveda as it has a high prevalence all
over world and in India. It is also
identified as a potential risk factor for many life-threatening diseases
like ischemic heart disease
and stroke.
The dissertation was made into two parts. The initial
part of the dissertation deals with review
of literature comprising of Nirukthi,
Paribhasha, Nidana, Roopa and Chikitsa
of Medoroga. It also includes incidence of dyslipidemia, lipid
metabolism, classification, clinical
feature and Management of Dyslipidemia. The later part includes materials and methods,
observation, result, discussion on observation and results, conclusion and summary.
The trial was registered prospectively in CTRI on
10/05/2023 with CTRI number:
CTRI/2023/05/052460. The present study was completed with 30 subjects in
2 groups- Trial group (Group A) and Control
group (Group B). Each Group had 15 subjects selected
randomly. Subjects in Group A were treated
Guduchyadi yoga. Coarse powders
of Guduchi, Triphala,
along with shodhita purana guggulu, was procured from GMP Certifies
Pharmacy. 24g of kwatha churna was added to 400ml of water and boiled in
open vessel until it was reduced to 50ml, to this 1.5 grams of shodhita
purana guggulu was added to prepare Guduchyadi Yoga. Subjects in
group B were treated with Navaka guggulu which
was procured from GMP certified pharmacy.
The interventions were administered for a span of 30 days. Assessment was done on 0th day, 30th day and 45th day. Assessment was done on basis of objective parameters. Objective parameters were
serum lipid levels. Additionally, efficacy on weight and BMI of the
subjects were also assessed.
Statistical
analysis for the above parameters was done using the Unpaired t-test, Repeated
measures of ANOVA, Paired t-test, Mann Whitney U Test, Friedman test, and
Wilcoxon Sign rank test.
On
comparing the results between the groups showed statistically non-significant
results on majority of parameters
suggesting that, both Guduchyadi churna and
Navaka guggulu had equal effect in the
management of medoroga.
However, based on effect size, oral
administration of the trial drug Guduchyadi Yoga is
more efficacious than the control drug Navaka Guggulu
in the management of Dyslipidemia. |